Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Print1
- Print1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Res Exp Med (Berl)1
Search Results
Sort by
- Bookedited by Laura Roberts.
- ArticleRing J, Duswald KH, Bachmann T, von Scheel J, Stephan W, Brendel W.Res Exp Med (Berl). 1978 Sep 25;173(3):209-18.Dog IgG was produced by fractionation procedures used for the production of clinically used i.v. gammaglobulins. Chemical modification of dog IgG was done by pepsin or beta-propiolactone treatment. The intravascular half-life of beta-propiolactone IgG was 8.5 +/- 2.1 days compared to 4.5 +/- 1.6 days of pepsin treated IgG. Tissue concentrations of radioactive labelled beta-propiolactone IgG were generally higher than of pepsin digested IgG. Pepsin treated Igg was degraded to a significantly higher extent (26% of the administered radioactivity was bound to fragments smaller than 6000 MW after three days) than beta-propiolactone IgG (9% fragments after the same interval, P less than 0.001). It is concluded that the short intravascular half-life of pepsin IgG cannot be explained by increased extravascular filling, but is due to rapid degradation and excretion via the kidneys. There was no obvious difference in elimination and organ distribution between standard and beta-propiolactone IgG.